Author

Cristina Ferreras

Observed names: C Ferreras, C. Ferreras, Cristina Ferreras Bárbara Pascual, Ferreras, Cristina

Institutions: Hospital Universitario La Paz, Instituto de Salud Carlos III, Hospital La Paz Institute for Health Research

Observed institutions: Hospital Universitario La Paz, Instituto de Salud Carlos III, Hospital La Paz Institute for Health Research

ORCID: 0000-0001-9595-4998

Observed ORCID: 0000-0001-9595-4998

OpenAlex ID: A5028565626

SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy

2021 · C Ferreras, B Pascual-Miguel, et al. · Frontiers in Cell and Developmental Biology · 55

Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity

2021 · Yasmina Mozo, David Bueno, et al. · Pediatric Hematology and Oncology · 28

The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus ‐6B encephalitis after naïve T ‐cell‐depleted allogeneic stem cell transplantation

2021 · Mercedes Gasior, Cristina Ferreras, et al. · Transfusion · 19

Facing CAR T Cell Challenges on the Deadliest Paediatric Brain Tumours

2021 · Cristina Ferreras, Lucía Fernández, et al. · Cells · 15

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

2021 · I. García-García, P. Guerra-García, et al. · Trials · 11

A Phase I/II Dose-Escalation Multi-Center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia: (RELEASE NCT04578210)

2021 · Antonio Pérez-Martínez, Alejandro Martín-Quirós, et al. · Blood · 1

Epigenetic modulation of NKG2D ligands enhances NKG2D-CAR T cell efficacy in neuroblastoma

2026 · Alfonso Navarro-Zapata, María Octavia De Santisteban, et al. · Journal of Translational Medicine

A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210)

2023 · Antonio Perez-Martinez, Cristina Ferreras, et al. · Transplantation and Cellular Therapy

A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210)

2022 · Antonio Perez, Cristina Ferreras, et al. · Blood

A Phase I Dose-Escalation Single Center Study To Evaluate The Safety Of Allogenic Memory T Cells Containing SARS-COV-2 Specific Lymphocytes As Adoptive Therapy in COVID19

2021 · Antonio Pérez‐Martínez, Cristina Ferreras, et al. · Bone Marrow Transplantation

Works count: 11

Citation count: 129

H-index: 5

I10-index: 5